Comparison of effectiveness between two different doses of intravenous dexmedetomidine as adjuvant to subarachnoid block for sub umbilical surgeries

Ayaskant Sahoo; Padmalatha Seelan; Gurucharan Dasari; Swathi Penmatsa

doi:10.20883/medical.e838

Authors

Ayaskant Sahoo Department of Anaesthesiology, Manipal - TATA Medical College, Jamshedpur, India https://orcid.org/0000-0002-2612-9211
Padmalatha Seelan Department of Anaesthesiology, NRI IMS, Visakhapatnam, India
Gurucharan Dasari Department of Anaesthesiology, NRI IMS, Visakhapatnam, India https://orcid.org/0009-0004-6891-8464
Swathi Penmatsa Medicover Hospitals, India

DOI:

https://doi.org/10.20883/medical.e838

Keywords:

dexmedetomidine, Alpha 2 agonist, Subarachnoid block, intravenous adjuvant to regional

Abstract

Background. Spinal anesthesia was a commonly used technique in anesthetic practice for lower abdominal and lower limb surgeries. To prolong the duration of bupivacaine spinal anesthesia adjuvants like α2 agonists and opioids have been used intrathecally. Clonidine and dexmedetomidine have also been found to prolong the duration of spinal anesthesia when given intravenous. Dexmedetomidine was more suitable adjuvant to spinal anesthesia compared to clonidine as it has more sedative and analgesic effects due to more selective α2A receptor agonist activity. Dexmedetomidine has been shown to prolong the duration of analgesia of spinal anaesthesia in various studies. Here we compare the two doses of Dexmedetomidine in prolonging the duration of analgesia.

Material and methods. 60 American Society of Anaesthesiologists(ASA) physical status I/II patients scheduled for elective lower abdominal and lower limb surgeries under spinal anesthesia were randomized into two groups of 30 each. Immediately after subarachnoid block with 3.5ml of 0.5% hyperbaric bupivacaine, Group A patients received a loading dose of 0.5µg/kg of dexmedetomidine intravenously in 100ml NS over 10 mins whereas Group B received 1.0µg/kg of dexmedetomidine intravenously in 100ml NS over 10 mins.

Results. Time for rescue analgesic were higher in Group B compared to Group A which was statistically significant but clinically the extra duration was insignificant. Time for two segment regression and duration of motor blockade was significantly prolonged in Group B. Requirement of Mephentermine was comparable in both the groups. There was no excessive sedation in both the groups.

Conclusion. Dexmedetomidine administered as isolated loading dose of 0.5 µg/kg IV immediately after spinal anaesthesia was clinically equi-efficacious in prolonging the duration of analgesia of spinal anaesthesia compared to a larger dose of 1.0 µg/kg. The side effect profile, hemodynamic stability, sedation levels, need for vasopressors and atropine were comparable in both groups.

Downloads

Download data is not yet available.

References

Adriaensen Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999 Feb;54(2):146-65. doi: 10.1046/j.1365-2044.1999.00659.x.

Gabriel JS, Gordin V. Alpha 2 agonists in regional anesthesia and analgesia. Curr Opin Anaesthesiol. 2001 Dec;14(6):751-3. doi: 10.1097/00001503-200112000-00024.

Keating GM. Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting. Drugs. 2015 Jul;75(10):1119-30. doi: 10.1007/s40265-015-0419-5

Tang C, Xia Z. Dexmedetomidine in perioperative acute pain management: a non-opioid adjuvant analgesic. J Pain Res. 2017 Aug 11;10:1899-1904. doi: 10.2147/JPR.S139387.

Santpur MU, Kahalekar GM, Saraf N, Losari A: Effect of intravenous dexmedetomidine on spinal anaesthesia with 0.5% hyperbaric bupivacaine in lower abdominal surgeries: A prospective randomized control study.Anesth Essays Res. 2016, 10:497-501. 10.4103/0259-1162.179319.

The jamovi project (2022). jamovi. (Version 2.3) [Computer Software]. Retrieved from https://www.jamovi.org.

Krishna Prasad GV, Khanna S, Jaishree SV: Review of adjuvants to local anesthetics in peripheral nerve blocks: Current and future trends. Saudi J Anaesth. 2020, 14:77-84. 10.4103/sja.SJA_423_19.

Allen TK, Mishriky BM, Klinger RY, Habib AS: The impact of neuraxial clonidine on postoperative analgesia and perioperative adverse effects in women having elective Caesarean section-a systematic review and meta-analysis. Br J Anaesth. 2018, 120:228-240. 10.1016/j.bja.2017.11.085.

Gertler R, Brown HC, Mitchell DH, Silvius EN: Dexmedetomidine: a novel sedative-analgesic agent. Proc(Bayl Univ Med Cent. 2001, 14:13-21. 10.1080/08998280.2001.11927725.

Dinesh CN, Sai Tej NA, Yatish B, Pujari VS, Mohan Kumar RM, Mohan CV: Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study. Saudi J Anaesth. 2014, 2:202-8. 10.4103/1658-354X.130719.

Lee MH, Ko JH, Kim EM, Cheung MH, Choi YR, Choi EM: The effects of intravenous dexmedetomidine on spinal anesthesia: comparision of different dose of dexmedetomidine. Korean J Anesthesiol. 2014, 4:252-7. 10.4097/kjae.2014.67.4.252.

Kavya UR, Laxmi S, Ramkumar V: Effect of intravenous dexmedetomidine administered as bolus or as bolus plus-infusion on subarachnoid anesthesia with hyperbaric bupivacaine. J Anaesthesiol Clin Pharmacol.2018, 34:46-50. 10.4103/joacp.JOACP_132_16.

Kubre J, Sethi A, Mahobia M, Bindal D, Narang N, Saxena A: Single dose intravenous dexmedetomidine prolongs spinal anesthesia with hyperbaric bupivacaine. Anesth Essays Res. 2016, 2:273-7. 10.4103/02591162.174465.

Hong JY, Kim WO, Yoon Y, Choi Y, Kim SH, Kil HK: Effects of intravenous dexmedetomidine on low-dose bupivacaine spinal anaesthesia in elderly patients. Acta Anaesthesiol Scand. 2012, 56:382-7. 10.1111/j.13996576.2011.02614.x.

Al Nobani MK, Ayasa MA, Tageldin TA, Alhammoud A, Lance MD: The Effect of Different Doses of Intravenous Dexmedetomidine on the Properties of Subarachnoid Blockade: A Systematic Review and Meta-Analysis. Local Reg Anesth. 2020, 15:207-215. 10.2147/LRA.S288726.